Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 3 1

Status

Completed 11Terminated 3Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Varenicline × Clear all
NCT02582008 2023-03-22

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
9 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma

NCT02856581 2022-07-27

Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
23 enrolled 7 charts
Thoracic

Lung Neoplasms

NCT00931021 2013-07-15

Smoking Cessation Treatment for Head and Neck Cancer Patients

Yale University

Phase EARLY_PHASE1 Terminated
7 enrolled

Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡